Altimmune to report fourth quarter and full year 2024 financial results and provide business update on february 27, 2025

Gaithersburg, md., feb. 20, 2025 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its fourth quarter and full year 2024 financial results on thursday, february 27, 2025.

ALT Ratings Summary

ALT Quant Ranking